TradeStory Research

Liquid biopsy's quiet bottleneck: who is building lab capacity first

Three diagnostics companies used their latest earnings calls to talk about labs, automation and cost per test. In this corner of health care, capacity may matter as much as demand.

The closed-weight AI race: where Anthropic is gaining and OpenAI is defending

October's industry notes put the competition among closed-weight labs in sharper focus. Anthropic leads in coding, OpenAI is defending on trust and value, and smaller labs are pushing into decision models.

The gas pipes behind AI power: what this week's reports tell you to watch

The latest gas reports show two clocks running at once. Majors and producers are posting strong quarters now, while new pipelines are being planned for 2030 and later.

What protects SoFi: the member economics behind the moat

SoFi's latest call says its edge is what each member is worth: better unit economics per product, more products per member and pricing it chooses not to give away. Here is what the evidence shows, how it compares with PayPal and Mastercard, and what would wear it down.

Beyond Evidence: the counter-drone and software shift behind Axon's new money

Axon's core evidence software still anchors the business, but a growing share of revenue now comes from newer products, with counter-drone among the fastest-growing. Here is where that new money comes from and what would confirm the shift.

Why Marvell slipped on reports it may buy Lumentum

Microsoft vs Alphabet: a clean beat against faster growth and a miss

AI security's share war: how to read who is gaining ground and who is giving it up

The latest earnings calls and 10-K filings point to one theme: buyers are consolidating security onto fewer platforms. Here is who the reports show taking deals, and from whom.

Surgical robots: who is gaining ground, who is defending it, and why it matters to you

In medical robotics, share is won by getting a system into the hospital and keeping the work flowing through it. The latest earnings calls show incumbents defending that position while challengers come in through new systems, other procedures and new regions.

The AI IPO test: what a $1.5 trillion Anthropic listing has to prove

The fear around Anthropic and OpenAI is mostly about a credit event spilling into public markets. The latest reports point somewhere else: valuation expectations, how much capital these companies are raising, and customers who can switch providers.

What protects Merck now: why access may matter more than price

Merck's latest call points to a moat built on reach, regulatory standing and pipeline lifecycle more than on premium pricing. Here is what the facts show, and what could wear it down.

The power pivot: who gains when bitcoin miners start hosting AI

Bitcoin miners are turning their power and sites into AI infrastructure. The early edge looks like contracts, partners and execution rather than raw megawatts, and the companies are telling that story in different ways.

How to spot pricing power in AI customer software before it shows up in price lists

The latest earnings calls from four customer-engagement software companies point the same way. Pricing power shows up as upsell, retention and margins, and AI features are giving customers a reason to spend more.

For us Normies: when the macro backdrop says step aside, and why that bar is so high

Our macro regime grade reads exit today, its highest level, and it has been there since early September. Here is what that grade means, why it is so hard to reach, and what our dashboard shows behind it.

For us Normies: why a cheap P/E can still be expensive

A low price-to-earnings ratio looks like a bargain sign, but it says nothing about where profits are heading. Growth-adjusted valuation adds that missing piece, and we walk through one live example from our data.

Surgical robots have a supply problem: where capacity, not demand, sets the pace

On the latest earnings calls, medical device makers talked less about finding buyers and more about building, shipping and stocking enough product. Who solves supply first is the story to follow.

The capacity squeeze in defense and aerospace, and who is building their way out

On the latest earnings calls, the companies that sounded strongest were talking about floor space, automation and supply chains, not demand. Here is what they said, and what to watch as those plans meet reality.

The gigawatt race: what AI capacity plans tell you about the frontier labs

AI build-out plans are now quoted in gigawatts and power gear, not chip counts. SpaceX, Meta, Amazon and Microsoft each describe the same constraint, and each is handling it differently.

Fundamentals in one number: how to read a company's health score

Fundamentals are a company's business numbers. One score can sum them up, if you know what goes into it and where it can mislead you. Micron is the worked example.

Data center connectivity: who makes it, where the money goes, who leads

The bitcoin miners still adding hashrate while peers chase AI

Some miners are moving their sites over to AI data centers, and that could leave fewer machines mining bitcoin for good. The latest earnings calls show which pure-play miners are still adding mining capacity, and which are building for both.

How power capacity decides the mining-to-AI pivot

Three companies are turning energized sites into AI and high-performance computing hosting. The gap between contracted and potential megawatts is the part to read closely.

For us Normies: what RSI says about momentum, and why overbought is not a warning

RSI is a 0 to 100 score of how hard a price has been pushing in one direction. Here is how to read it, and what one stock's trend looks like next to it.